KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Operating Expenses (2016 - 2026)

National Health Investors filings provide 18 years of Operating Expenses readings, the most recent being $78.0 million for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 39.31% to $78.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $261.0 million, a 20.39% increase, with the full-year FY2025 number at $239.0 million, up 12.78% from a year prior.
  • Operating Expenses hit $78.0 million in Q1 2026 for National Health Investors, up from $69.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $78.0 million in Q1 2026 to a low of $49.5 million in Q4 2023.
  • Median Operating Expenses over the past 5 years was $54.8 million (2024), compared with a mean of $57.2 million.
  • Biggest five-year swings in Operating Expenses: soared 49.65% in 2022 and later dropped 28.34% in 2023.
  • National Health Investors' Operating Expenses stood at $69.1 million in 2022, then dropped by 28.34% to $49.5 million in 2023, then grew by 9.42% to $54.2 million in 2024, then grew by 28.79% to $69.8 million in 2025, then grew by 11.8% to $78.0 million in 2026.
  • The last three reported values for Operating Expenses were $78.0 million (Q1 2026), $69.8 million (Q4 2025), and $57.6 million (Q3 2025) per Business Quant data.